BioMarker Strategies


Biomarker Strategies is a company dedicated to advancing biomarker research and development. Their mission is to provide innovative solutions and expertise in biomarker discovery, validation, and commercialization to support personalized medicine and improve patient outcomes.

Industries

biotechnology
health-care
health-diagnostics

Nr. of Employees

small (1-50)

BioMarker Strategies

Baltimore, Maryland, United States, North America


Products

SnapPath Cancer Diagnostics System

A diagnostics system that automates the processing of live solid tumor cells from fresh samples for ex vivo exposure to targeted therapies, enabling the generation of PathMAP Functional Signaling Profiles.

PathMAP Functional Signaling Profiles

Biomarker tests that provide predictive information on individual response to targeted treatments for solid tumors, based on the dynamic response of live cell signaling pathways.


Services

Biomarker strategy consulting

Consulting on biomarker selection, translational strategy, and alignment with clinical development goals.

Assay development and validation services

Development and analytical validation of biomarker assays to predefined performance criteria.

Clinical trial biomarker integration

Support for incorporating biomarkers into clinical protocols, including sampling plans and endpoint definitions.

Expertise Areas

  • Biomarker strategy and development
  • Clinical biomarker integration
  • Assay development and validation
  • Translational medicine
  • Show More (2)

Key Technologies

  • Immunoassays
  • PCR-based biomarker assays
  • Assay validation protocols
  • Biostatistical analysis
  • Show More (1)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.